Overdose Prevention Capacity Assessment Tool

Monitoring and Reporting for the Overdose Data to Action Cooperative Agreement

OD2A Capacity Self Assessment 2.0_Clean 08122021

OMB: 0920-1283

Document [docx]
Download: docx | pdf



Self-Assessment Tool

 

Instructions: This tool is intended to guide CDC OD2A recipients in a systematic and objective assessment of their existing capacity to address the overdose epidemic.  Insight generated from application of this tool will be used to 1) guide CDC’s programmatic and scientific technical assistance and resources we provide to recipients and 2) measure progress in building and sustaining overdose prevention capacity.

This tool characterizes two main domains of capacity: overdose content specific and broader infrastructure capacity.  Within each of these broad domains, more specific elements are defined and described.  Recipients can use these descriptions and the included benchmarks to inform their self-assessment of their current status. The activities being assessed in this tool are those related to the OD2A goals of increasing comprehensiveness and timeliness of surveillance data; building jurisdictional and local capacity for public health programs determined to be promising based on research evidence; making Prescription Drug Monitoring Programs (PDMPs) easier to use and access; and working with health systems, insurers, and communities to improve opioid prescribing.


For questions about this survey contact your project officer



Multilevel Leadership

Multilevel Leadership is defined as the people and processes that make up leadership at all levels that interact with and have an impact on the program. It includes leadership in the state health department or other organizational unit in which the program is located, as well as leadership from other decision-makers, leadership within the program beyond the program manager and across programs that have related goals, and leadership at the local level.


Respondents please select the level that best reflects your current capacity


Leadership for overdose prevention exists across levels

No leadership exists currently

Leadership exists in only one level within the health department

(e.g., within the overdose prevention program)

Executive leadership exists at health department (i.e., State/Local/Territorial Health Official) and on multiple levels within and across programs in the health department (e.g., leadership from injury prevention, vital records, infectious disease, maternal and child health, etc.)

Leadership exists throughout multiple levels of government from executive leaders (e.g., Mayors/ Governors) to legislative entities (e.g., city or county councils, state legislators) and across to other heads of department

Unsure

Multilevel Leadership, Continued



Leadership for overdose surveillance exists across levels

No leadership exists currently

Leadership exists in only one level within the health department

(e.g., within the overdose surveillance program)

Executive leadership exists at health department (i.e., State/Local/Territorial Health Official) and on multiple levels within and across programs in the health department (e.g., leadership from injury prevention, vital records, infectious disease, maternal and child health, etc.)

Leadership exists throughout multiple levels of government from executive leaders (e.g., Mayors/ Governors) to legislative entities (e.g., city or county councils, state legislators) and across to other heads of department

Unsure

Leadership to incorporate health equity in overdose prevention exists across levels”

No leadership exists currently

Leadership exists in only one level within the health department


Executive leadership exists at health department (i.e., State/Local/Territorial Health Official) and on multiple levels within and across programs in the health department (e.g., leadership from injury prevention, vital records, infectious disease, maternal and child health, etc.)

Leadership exists throughout multiple levels of government from executive leaders (e.g., Mayors/ Governors) to legislative entities (e.g., city or county councils, state legislators) and across to other heads of department

Unsure




Multilevel Leadership, Continued


Existing coordinating unit or body in health department

Ad-hoc meetings are identified as a need within the health department

Leaders meet regularly to discuss status of work across the health department

Leaders coordinate activities across the health department (e.g., strategic planning of efforts)

Health department leaders coordinate with leaders from other sectors (i.e., law enforcement, healthcare, PDMP, treatment services, etc.) to develop and/or review and update coordinated response

Unsure




Notes or comments:





Evaluation Capacity

Evaluation capacity is defined as the ability to develop evaluation plans, conduct evaluations, and use evaluation findings for decision making to improve programs, policies, and procedures.


Respondents, please select the level that best reflects your current capacity



Evaluation expertise











An evaluation position exists and/or work will be contracted but it is not currently filled or in place

An evaluator and/or contract mechanism is in place

Overdose program has sufficient evaluation staff (e.g., internal evaluator(s), and/or consultant(s) dedicated to evaluation efforts) 

Overdose program has high quality dedicated evaluation staff or consultants, and all essential positions/ responsibilities are filled

Unsure

Technology for evaluation, data access, management, and analysis


There are currently no resources available to support evaluation data access and analysis

Limited resources are available to increase evaluation data access and data management via data use agreements, partnerships, or technology

Sufficient resources are available for technology needed to manage and analyze evaluation data

Resources for necessary technology are available and multiple staff positions contribute to analysis of evaluation data

Unsure



Evaluation Capacity, Continued



Staff (internal or contract) capacity to collect, manage and analyze evaluation data

There are currently no staff available to collect primary data and use existing programmatic data

Limited evaluation

staff are available to collect primary evaluation data, use existing programmatic data, and manage and analyze all evaluation data


Sufficient evaluation

staff are available to collect primary evaluation data, use existing programmatic data, and manage and analyze all evaluation data


Resources are integrated across multiple staff positions or contracts to collect primary evaluation data, use existing programmatic data, and manage and analyze all evaluation data


Unsure

Dissemination and use of evaluation findings

There is currently no routine sharing of evaluation findings


Data dissemination planning is occurring and/or data is shared on a limited basis and mechanisms for distribution are being explored




Data dissemination occurs regularly, and formal mechanisms exist for disseminating evaluation data to key partners (e.g., regular meetings between evaluation and program staff, evaluative data dashboard, legislative reports)

Data dissemination occurs often (e.g., more than once a year), formal dissemination mechanisms exist and are tailored to the needs of partners. Additional training and technical assistance may be provided to help partners to understand and take action on the data they receive


Unsure



Notes or comments:

Networked Partnerships

Networked partnerships are defined as strategic partnerships at all levels (national, state, and local) across sectors (health systems, public safety) with multiple types of organizations (government, nonprofit) that enhance coordination of efforts toward a common goal, foster champions, and contribute to sustainability.

Respondents please select the level that best reflects your current capacity

Partnerships with public sectors

No partnerships exist with public sector entities

One or two public sectors

Three public sectors

Four or more public sectors

Unsure

Partnerships across jurisdiction levels

No partnerships across jurisdictional levels

Only within your jurisdiction level (e.g., state or territory)

Within your jurisdiction and one additional level (e.g., state and city)

Partnerships across all levels (state/territory, county, and city)

Unsure

Public-private partnerships (e.g., private entities are non-profits, universities)

No public-private partnerships exist

Public partnerships only

Mix of private and public (health only)

Mix of private and public (health and non-health)

Unsure

Level of engagement for prevention activities

No partners are engaged in prevention activities

Partners have situational awareness of prevention activities

Partners regularly participate in and contribute to prevention activities; may serve as a champion

Prevention focused partnerships are solidified via resource sharing or operational agreements like data sharing agreements, memoranda of understanding (MOUs), etc.

Unsure











Networked Partnerships, Continued

Level of engagement for surveillance activities

No partners are engaged in surveillance activities

Partners have situational awareness of surveillance activities

Partners regularly participate in and contribute to surveillance activities; may serve as a champion

Surveillance focused partnerships are solidified via resource sharing or operational agreements like data sharing agreements, memoranda of understanding (MOUs), etc.

Unsure

Shared planning of prevention activities

There is no shared planning of prevention activities

Prevention planning occurs exclusively within the health department with situational awareness of partner activities

Prevention planning occurs by the health department in consultation with partners

Prevention planning is strategic and deliberately coordinated with partners and the health department to plan, execute, and assess impact of prevention strategies

Unsure

Shared planning of surveillance activities

There is no shared planning of surveillance activities

Surveillance planning occurs exclusively within the health department with situational awareness of partner activities

Surveillance planning occurs by the health department in consultation with partners

Surveillance planning is strategic and deliberately coordinated with partners and the health department to plan, execute, and assess impact of prevention strategies

Unsure

Shared planning of health equity efforts

There are no shared planning of health equity activities

Health equity planning occurs exclusively within the health department with situational awareness of partner activities

Health equity planning occurs by the health department in consultation with partners

Health equity planning is strategic and deliberately coordinated with partners and the health department to plan, execute, and assess impact of health equity activities

Unsure



Notes or comments:



Responsive Plans and Planning

Responsive planning as part of the state strategic plan is defined as a dynamic process that evolves and responds to contextual influences such as changes in the science, health department priorities, funding levels, and external support from the public and leadership. It also promotes action and the achievement of public health goals.

Strategic plan for opioid overdose response or opioid response plan

No strategic plan or opioid response plan exists

Need for a strategic plan for opioid overdose is recognized and efforts are underway to develop a plan

A Strategic plan for opioid overdose exists. 

The strategic plan for opioid overdose is a living document. Partners actively use and consult the plan in their work and future planning efforts

Unsure

Overdose response plan that addresses all substances (e.g., stimulants) and strategies to address them

No plan exists currently to address all overdoses. 

Need to broaden initial opioid response plan to address all overdose substances is recognized and efforts are underway to broaden it.

Current strategic plan for opioid overdose addresses other substances, but in a limited manner (e.g., response strategies still primarily focus on opioids)

The strategic plan is comprehensive; addresses multiple substances involved in overdose and strategies to address them. 

Unsure

The strategic plan/overdose response plan pertains to the following entities:

No plan exists currently. 

Public health governmental entities only (e.g., Territory/State/City/County health departments)

All governmental agencies/entities at a variety of levels in your jurisdiction 

All governmental and non-governmental entities in your jurisdiction and at a variety of levels (e.g., public and private)

Unsure

Plan coordination

There is no planning for coordination

Strategic plan has limited coordination

Strategic plan is coordinated across sectors or levels for at least one strategy

Strategic plan is coordinated across sectors or levels for multiple strategies

Unsure

Sustainability plan

There is no planning for sustainability

Need recognized but no action taken on a sustainability plan

Sustainability plan only applies for one or two strategies

Sustainability plan exists for overdose prevention

Unsure





Responsive Plans and Planning, Continued



Plan updates

There is no known updating process for the plan

Plan is updated rarely or every 3 years

Plan is only visited when there are emergent needs

Plan is a living document; regularly reviewed and updated to address trends and respond to needs 

Unsure

Overdose response incorporated into other jurisdictional planning efforts (e.g., State Health Improvement Plan (SHIP))

Overdose response is not incorporated into jurisdictional planning efforts

Overdose response needs to be incorporated into jurisdictional planning efforts

Overdose response plan is referenced in jurisdictional planning efforts like the SHIP or action plan

Overdose response plan is integrated into jurisdictional planning efforts like the SHIP or action plan

Unsure



Notes or comments:



Data to Action

Data to Action refers to identifying and working with data in a way that promotes action and ensures that data are used to promote public health goals.

Respondents please select the level that best reflects your current capacity

Needs assessment

No needs assessment has been performed

Needs assessment performed but limited in scope

Needs assessment performed at regular intervals; but lacks data on specific needs of disproportionately affected populations or regions/areas

Needs assessment performed on a regular basis; additional needs assessments conducted about disproportionately affected populations or regions/areas

Unsure

Data sharing

No data sharing occurs currently

Data sharing is limited to within the health department

Data sharing occurs across several governmental entities and Data Use Agreements may exist formalizing these relationships

Data sharing is formalized by legal documents like Data Use Agreements; data sharing is enhanced through shared resources (e.g., health department pays for PDMP analysts or epidemiologists) and occurs across jurisdictions. 

Unsure

Data to Action, Continued




Use/linkage of Drug Overdose Data

The health department does not regularly conduct drug overdose surveillance activities

Health department conducts analysis and trend reporting of mortality data (e.g., vital records death data and medical examiner death data)

Surveillance activities include analysis and trend reporting of mortality data and morbidity data (e.g., emergency department discharge and hospital inpatient data and syndromic surveillance)

Health department conducts data linkages with mortality and/or morbidity drug overdose data and other surveillance data sources (e.g., PDMP, EMS, or administrative billing discharge data)

Unsure

Access and use of Non-traditional data sets (e.g., Law Enforcement, Criminal Justice, Naloxone Administrations, ODMAP, Neonatal Abstinence Syndrome, Syringe Associated Infections, Social Service or Child Welfare, Medicaid, Worker's Compensation, Veteran's)

These data are not accessed or used currently

Access to non-traditional data has been identified as a need and efforts are underway to gain access.

Health department has access to and conducts trend analysis with non-traditional data sets

Health department conducts data linkages with non-traditional data sets with morbidity and/or mortality data

Unsure

Data to Action, Continued



Data dissemination

Data are not currently disseminated

Data dissemination planning is occurring and mechanisms for distribution are being explored

Data dissemination occurs regularly, and formal mechanisms exist for disseminating data to key partners (e.g., data dashboard, legislative reports, PDMP reports to licensing boards)

Data dissemination occurs often (e.g., more than once a year), formal dissemination mechanisms exist and are tailored to the needs of various partners. Additional training and technical assistance may be provided to help partners to understand and take action on the data they receive

Unsure

Data action plans (e.g., plans that guide partners on actions that can be taken based on drug trends or overdose spikes in their areas)

There is no interest and no data action plans exist for my jurisdiction

Data action plans are a recognized need but no current guidance has been developed

Data action plans exist but are limited in scope (e.g., only address opioids) and offer a narrow list of activities that can be undertaken

Data action plans exist, cover all possible overdose substances, and are widely used by partners to plan overdose responses efforts

Unsure



Notes or comments:



Managed Resources

Managed resources refers to funding and social capital or relationships that produce social benefits.

Respondents please select the level that best reflects your current capacity

Funding sources

There are currently no funds available to support prevention efforts

Only CDC funds overdose prevention efforts in my jurisdiction

CDC and other federal entities fund overdose prevention efforts in my jurisdiction

An array of partners fund overdose prevention efforts in my jurisdiction. This may include the following: CDC, other federal entities, jurisdictional funds, private entities, and/or foundations

Unsure

Scope of funded activities

There are currently no funds available to support prevention efforts

Funds support work implemented only within the state or local or territorial health agency

Funds support work implemented outside of the health agency across public government entities at multiple levels to expand and enhance prevention activities (e.g., fund local health districts/ departments)

Funds support prevention efforts implemented by partners across sectors or levels. This includes funding staff positions in other entities outside the health department (e.g., PDMP administrators, recovery coaches)

Unsure













Managed Resources, Continued

Staffing levels

Health agency does not have the resources or mechanisms to staff all essential positions needed to support overdose prevention efforts (i.e. case abstractors, epi, prevention specialists, evaluators etc.)

Overdose program has the resources but not the infrastructure or mechanisms to fill staffing positions to manage and operate overdose prevention programs (e.g., vacancies are difficult to fill)

Overdose program has sufficient staff to manage and operate overdose prevention programs

Overdose program has high quality staff to manage and operate programs and all essential positions are filled (e.g., vacancies have been easy to fill and attract high quality candidates to function as epis, prevention specialists, evaluators, case abstractors, etc.)

Unsure

Resource sharing

Health department does not share any resources with partners

Health department shares limited resources with a few partners (e.g., funding positions or efforts in partner agencies, providing training or technical assistance) 

Health department and partners share resources (e.g., in-kind staff, training, technical assistance)

Health department and partners share resources in coordinated and strategic manner. Resources are shared at multiple levels and forms (e.g., in-kind staff, training, technical assistance)

Unsure















Managed Resources, Continued

Social capital (e.g., features of an organization like networks, norms, and social trust that facilitate coordination and cooperation for mutual benefit)

Potential partners do not currently work together; therefore, no social capital exists

Overdose prevention partners have a low degree of social capital (e.g., partners lack diversity, trust, coordination and cooperation)

Overdose prevention partners have sufficient social capital to move prevention efforts forward, but improvements could be made to strengthen partner trust, diversity, coordination, and cooperation

Overdose prevention partners have high degree of social capital (e.g., trust is high, partnership is diverse, and active levels of coordination and cooperation exist)

Unsure



Notes or comments:



Topical Capacity

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Conducting Public Health Surveillance (e.g., syndromic vs. conventional surveillance, disproportionately affected areas identified)

No systematic public health surveillance of opioid misuse and overdose

Limited public health surveillance of opioid misuse and overdose that does not extend beyond overdose morbidity/mortality and only sometimes informs intervention planning

Public health surveillance of misuse and overdose as well as key risk factors. Data informs intervention planning and action

Public health surveillance data on opioid misuse, overdose, risk factors and protective factors is a critical part of the recipient’s response to the opioid epidemic

Recipient has implemented comprehensive public health surveillance as well as innovative approaches such as linking datasets or conducting rapid needs assessments



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Medical Examiners/Coroners/Toxicologists share data with public health agency on drug overdose deaths

No data sharing

Limited data sharing

Some data sharing, but lack full state coverage, receive data slowly or receive data inconsistently

Data sharing across the state in a timely manner with some problems

Rapid data sharing and ongoing communication



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Analysis and dissemination of ME/C data including toxicology by health department

No ongoing analysis or dissemination

Some basic analyses and dissemination, but is periodic and inconsistent

Ongoing analysis and dissemination of data, but not well integrated into prevention and response efforts

Consistent ongoing dissemination of the data that is well integrated into prevention and response efforts

Consistent dissemination of data to support prevention and response efforts coupled with innovative analyses and dissemination efforts



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Capacity to conduct comprehensive death investigation of drug overdose deaths by ME/C agencies

Death investigations tend to use limited toxicology screens (e.g., do not test for fentanyl) and provide limited information beyond the death certificate

Death investigations tend to provide only basic information or vary substantially in quality across county ME/C agencies

Death investigations tend to provide useful information on the circumstances of drug overdose deaths as well as detect fentanyl and fentanyl analogs, but may lack resources to conduct autopsies and comprehensive toxicology screens on all cases

Death investigations are thorough including autopsy, comprehensive toxicology testing, and field investigations that provide actionable insights into the circumstances of drug overdose deaths

Death investigation is comprehensive and involves innovative components such as fatality review



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Naloxone tracking and analysis of administration data to identify hot spots 

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Hospital, healthcare, or emergency systems (e.g., to increase access to timely data EHR/PDMP integration, quality improvement initiatives, CDC guideline concordance)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Access to any rapid and reliable data on drug overdoses (e.g., Emergency Department, EMS, or other data)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Provider support & education (e.g., academic detailing, guideline concurrence, addiction medicine training, opioid prescribing and tapering training)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Public safety/first responders (police, EMS, Fire, 911, poison control) like training on naloxone administration, Good Samaritan Laws, or SUD; quick response teams

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Mass media or awareness campaigns (anti-stigma, information about local treatment and recovery resources, and Good Samaritan Laws)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

PDMP (e.g., mandatory use, identifying high prescribers, prescriber reports)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Opioid overdose education and naloxone distribution (harm reduction education, SUD training, and targeted outreach)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Health Insurers/payers (Medicare/Medicaid/Workers Comp) to increase treatment access (e.g., removing prior authorization, lock-in programs, coverage of non-opioid pain management treatment)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.

Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)



Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Linkage to care (peer support, warm handoff, wraparound services such as mental health, transportation, or housing services in variety of settings from community based Quick Response Teams, ERs, first responders, and harm reduction organizations, criminal justice)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.

Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Substance use treatment (e.g., expanding access by integrating MAT into primary care, buprenorphine waiver, accessibility, co-locating treatment in high-risk settings)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Identification of populations who are disproportionately affected by overdose, assessment of needs, and prioritized initiatives to address needs (e.g., AA, NA/AI, Women of reproductive age, Adolescents, Senior Citizens, Chronic Pain Patients)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)



Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Incorporating Health Equity into Overdose Efforts (e.g., implementing health equity initiatives, utilization of health equity indicators, leveraging partnerships to address health equity)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial initiatives, but important program gaps or challenges remain

Initiatives are developed but are either 1) targeted to the general population and not specifically to those in need or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have targeted initiatives to those in need (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy have been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)







Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Justice system and its involved populations (e.g., linkage and continuity of care in corrections and probation; drug courts or drug diversion programs; naloxone and SUD training for correction and probation officers)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) implemented with the general population and not specifically to priority populations or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have prioritized initiatives to those disproportionately affected (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy has been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)



Topical Capacity, Continued

Please select the description that best fits your health agency's capacity related to the topic. If you select the leftmost column you will be prompted to identify the barriers preventing capacity building for this function. Please select the top three to five barriers that apply (common list of barriers for all topics can be found at the end of this section).

Harm reduction initiatives (e.g. support of syringe service programs, safer injection education programs, outreach to people who use drugs)

No efforts are currently underway

Preliminary efforts and plans are underway (e.g., an action plan)

Have assessed and developed initial responses, but important program gaps or challenges remain

Initiatives are developed but are either 1) targeted to the general population and not specifically to those in need or 2) a few minor program gaps or challenges remain (resource plan in development to fill gaps)

Have targeted initiatives to those in need (e.g., data may be shared and discussed - multilateral sharing). All gaps and challenges related to implementing strategy have been addressed.



Challenges and Barriers

If you selected the left-most column, select three to five challenges or barriers from the list below:

Lack of personnel due to funding issues

Lack of personnel due to hiring issues

Lack of trained personnel

Lack of subject matter experts

Lack of plans/incomplete plans

Legal barriers

Administrative barriers

Issues with procurement/contracting process

Lack of equipment

Lack of IT equipment

Lack of IT systems

Lower priority function

Lack of supporting infrastructure

Corrective actions and/or exercising is required

Other (please explain)





Shape1 33


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorGeller, Amanda (CDC/DDNID/NCIPC/DOP)
File Modified0000-00-00
File Created2022-06-12

© 2024 OMB.report | Privacy Policy